1.Date of occurrence of the change:2021/10/27
2.Elected or changed position (Please enter institutional director, institutional supervisor, independent director, natural-person director or natural-person supervisor): Institutional director, natural-person director and natural-person supervisor.
3.Title and name of the previous position holder:
Director Tessie Che
Director Michael Chang
Director Frank Chen, Representative of Hui Hong Investment Co. Ltd
Director Tamon Tseng, Representative of Hui Hong Investment Co. Ltd
Director Tony Chow, Representative of Hui Hong Investment Co. Ltd
Supervisor Cheng-Wei Ma
4.Resume of the previous position holder:
Director Tessie Che/ Chairperson of the Board and General Manager, Amaran Biotechnology, Inc.
Director Michael Chang/ Chairperson of the Board and CEO, OBI Pharma Inc.
Director Frank Chen/ Vice President, Investment Management Department and Special Assistant to President, Ruentex Group
Director Tamon Tseng/ Special Assistant to the Legal Affairs Department, Ruentex Industries, Ltd.
Director Tony Chow/ Senior Partner, Tony Chow & Co.
Supervisor Cheng-Wei Ma/Senior Manager, Investment Management Department, Ruentex Group
5.Title and name of the new position holder:
Director Tessie Che
Director Michael Chang, Representative of OBI Pharma Inc.
Director Frank Chen, Representative of OBI Pharma Inc.
Director Ming-Tain Lai, Representative of OBI Pharma Inc.
Director Tamon Tseng, Representative of Hui Hong Investment Co. Ltd
Supervisor Wan-Fang Ting
6.Resume of the new position holder:
Director Tessie Che/ Chairperson of the Board and General Manager, Amaran Biotechnology, Inc.
Director Michael Chang/ Chairperson of the Board and CEO, OBI Pharma Inc.
Director Frank Chen/ Vice President, Investment Management Department and Special Assistant to President, Ruentex Group
Director Ming-Tain Lai/ Chief Scientific Officer, OBI Pharma Inc.
Director Tamon Tseng/ Special Assistant to the Legal Affairs Department, Ruentex Industries, Ltd.
Supervisor Wan-Fang Ting/ Manager, Investment Management Department, Ruentex Group
7.Circumstances of change (Please enter “resignation”, “dismissal”, “term expired”, “death” or “new appointment”): New appointment
8.Reason for the change: Full re-election of directors and supervisors in advance.
9.Number of shares held by the new position holder when elected:
Director Tessie Che/ 759,517 shares
Director Michael Chang/ 64,915,252 shares
Director Frank Chen/ 64,915,252 shares
Director Ming-Tain Lai/ 64,915,252 shares
Director Tamon Tseng/ 5,468,391 shares
Supervisor Wan-Fang Ting/ 0 shares
10.Original term (from __________ to __________): From April 23, 2019 to April 22, 2022
11.Effective date of the new appointment: 2021/10/27
12.Turnover rate of directors of the same term: Not applicable
13.Turnover rate of independent directors of the same term: Not applicable
14.Turnover rate of supervisors of the same term: Not applicable
15.Change in one-third or more of directors (Please enter “Yes” or “No”): Not applicable
16.Any other matters that need to be specified: None